Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer

Clinical trial NCT00003251 · UNKNOWN

Trial details

NCT number: NCT00003251
Sponsor: University of Illinois at Chicago
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Drug/Agent Toxicity by Tissue/Organ Head and Neck Cancer Radiation Toxicity

Start date: 1997-12-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.